Europe is slipping ever further behind the US in innovation in the drug industry and needs to revamp its research and healthcare systems to reverse the trend, according to a report to be released by the European Commission next month.

The US is increasingly dominating new medicine development at Europe's expense, when measured by labour productivity, influential patent filings, research collaboration and new drug launches, it says.